Drug Shortage Report for MOUNJARO

Last updated on 2025-02-03 History
Report ID 249489
Drug Identification Number 02541076
Brand name MOUNJARO
Common or Proper name tirzepatide injection
Company Name ELI LILLY CANADA INC
Market Status MARKETED
Active Ingredient(s) TIRZEPATIDE
Strength(s) 7.5MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS
Packaging size 3 mL single-dose vial
ATC code A10BX
ATC description
Reason for shortage Other (Please describe in comments)
Anticipated start date 2025-02-25
Actual start date
Estimated end date Unknown
Actual end date
Shortage status Anticipated shortage
Updated date 2025-02-03
Company comments Due to an increase in demand and limited inventory of Mounjaro 7.5 mg vials. All doses of KwikPen 2.5 mg to 12.5 mg are available and KwikPen supply will be prioritized moving forward. For any questions, please contact our Lilly Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).
Health Canada comments
Tier 3 Status No
Contact Address EXCHANGE TOWER, 130 KING STREET WEST
TORONTO, ONTARIO
CANADA M5X 1B1
Company contact information Lilly Canada’s Customer Response Centre 1-888-545-5972.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2025-02-03 French Compare
v1 2025-02-03 English Compare

Showing 1 to 2 of 2